Campbell JE, Mller TD, Finan B, DiMarchi RD, Tschp MH, DAlessio DA
As pharmaceutical companies, policymakers, and healthcare providers collaborate to tackle these challenges, obesity therapeutics will not only reshape the pharmaceutical landscape but also redefine the broader relationship between health, longevity, and lifestyle
The inclusion of NAPAs quality improvement measure in the CMS QPP MIPS program exemplifies our commitment to patient safety and innovation, he said
MAD, MDF, and EEM conceptualized the study
doi: 10.1152/ajpendo.00347.2016 174 AsmarMAsmarASimonsenLGasbjergLSSparre-UlrichAHRosenkildeMMet al